computer-aided diagnosis (cAD) systems hold potential to improve the diagnostic accuracy of thyroid ultrasound (US). We aimed to develop a deep learning-based US cAD system (dcAD) for the diagnosis of thyroid nodules and compare its performance with those of a support vector machine (SVM)-based US CAD system (sCAD) and radiologists. dCAD was developed by using US images of 4919 thyroid nodules from three institutions. Its diagnostic performance was prospectively evaluated between June 2016 and February 2017 in 286 nodules, and was compared with those of sCAD and radiologists, using logistic regression with the generalized estimating equation. Subgroup analyses were performed according to experience level and separately for small thyroid nodules 1-2 cm. There was no difference in overall sensitivity, specificity, positive predictive value (PPV), negative predictive value and accuracy (all p > 0.05) between radiologists and dCAD. Radiologists and dCAD showed higher specificity, PPV, and accuracy than scAD (all p < 0.001). In small nodules, experienced radiologists showed higher specificity, ppV and accuracy than scAD (all p < 0.05). In conclusion, dCAD showed overall comparable diagnostic performance with radiologists and assessed thyroid nodules more effectively than sCAD, without loss of sensitivity.
overall diagnostic performance. Table 2 lists the performance measures of the deep learning-based US CAD system (dCAD), the SVM-based CAD system (sCAD), and all radiologists in diagnosing thyroid malignancy. The radiologists showed higher specificity (76.9% vs. 58.5%, p = 0.001), positive predictive value (PPV) (83.1% vs. 72.3%, p = 0.001) and accuracy (86.4% vs. 75.9%, p < 0.001) than sCAD. There was no significant difference in all performance measures between radiologists and dCAD (p value range, 0.137 to 0.862). dCAD also demonstrated higher specificity (80.0% vs. 58.5%, p < 0.001), PPV (84.5% vs. 72.3%, p < 0.001) and accuracy (86.0% vs. 75.9%, p < 0.001) than sCAD.
Diagnostic performance according to the experience level of the radiologists. Table 3 shows the performance measures of the CAD systems and radiologists according to different experience levels in thyroid imaging. The experienced radiologist group showed higher specificity (87.2% vs. 58.1%, p < 0.001), PPV (89.2% vs. 71.2%, p < 0.001), and accuracy (90.8% vs. 75.5%, p < 0.001) than sCAD. However, none of the performance measures significantly differed between the experienced radiologist group and dCAD. When comparing the two CAD systems, dCAD had higher specificity (84.9% vs. 58.1%, p < 0.001), PPV (87.3% vs. 71.2%, p < 0.001) and accuracy (88.0% vs. 75.5%, p < 0.001) than sCAD.
In the inexperienced radiologist group, there were no significant differences in all of the performance measures between radiologists and each CAD systems (p value range, 0.145 to 0.409) ( Table 3) . Table 2 . Overall diagnostic performance of CAD systems and radiologists for diagnosing thyroid malignancy in the validation data set (n = 286). Note -95% confidence intervals are shown in parentheses.
Diagnostic performance in small thyroid nodules 1-2 cm in Size. Among the 286 thyroid nodules, 84 (29.4%) were 1-2 cm in maximum diameter. Of the 84 small thyroid nodules, 36 (42.9%) were benign and 48 (57.1%) were malignant. None of the patient and nodule characteristics of small thyroid nodules significantly differed between the experienced radiologist and inexperienced radiologist groups ( Supplementary Table S1 ). For all small thyroid nodules (n = 84), there were no significant differences in diagnostic performance between radiologists and each CAD systems ( Supplementary Table S2 ). However, when performing subgroup analyses according to the experience level of the radiologists, the experienced radiologist group demonstrated significantly higher specificity (95.2% vs. 61.9%, p = 0.011), PPV (95.2% vs. 71.4%, p = 0.023) and accuracy (95.4% vs. 76.7%, p = 0.006) than sCAD ( Supplementary Table S3 ).
In the experienced radiologist group, radiologists tended to show higher specificity (95.2% vs. 81.0%, p = 0.089) and accuracy (95.4% vs. 88.4%, p = 0.084) than dCAD, although the differences were not statistically significant. In addition, dCAD tended to show higher specificity (81.0% vs. 61.9%, p = 0.095), PPV (84.0% vs. 71.4%, p = 0.089), and accuracy (88.4% vs. 76.7%, p = 0.056) than sCAD in the experienced radiologist group ( Supplementary Table S3 ).
In the inexperienced radiologist group, there were no significant differences in all performance measures between radiologists and both CAD systems (p value range, 0.104 to 0.368).
Incorrectly classified cases by radiologists or CAD systems. The radiologists incorrectly classified 39 cases (13.6%, 39 of 286) in the validation data set, of which there were 9 misclassified cancers. These consisted of four (44.4%, 4 of 9) cases of follicular variant of papillary thyroid carcinoma (FVPTC) and five (55.5%, 5 of 9) cases of minimally invasive follicular thyroid carcinoma. sCAD incorrectly classified 69 cases (24.1%, 69 of 286) in the validation data set, of which there were 11 misclassified cancers. These consisted of eight (72.7%, 8 of 11) cases of conventional papillary thyroid carcinoma, one (9.0%, 1 of 11) case of FVPTC, one (9.0%, 1 of 11) case of minimally invasive follicular thyroid carcinoma and one (9.0%, 1 of 11) case of medullary thyroid carcinoma. dCAD incorrectly classified 40 cases (14.0%, 40 of 286) in the validation data set, of which there were 12 misclassified cancers. These consisted of four (33.3%, 4 of 12) cases of conventional papillary thyroid carcinoma, two (16.7%, 2 of 12) cases of FVPTC, five (41.7%, 5 of 12) cases of minimally invasive follicular thyroid carcinoma and one (8.3%, 1 of 12) case of medullary thyroid carcinoma. Among the misclassified cancers by dCAD, 50% (6 of 12) were also misclassified by radiologists as well.
Discussion
Our study results demonstrated that dCAD had performance comparable to radiologists for diagnosing thyroid malignancy, regardless of the experience level of the radiologists. Compared to sCAD, dCAD showed overall significantly improved specificity, PPV, and accuracy, while maintaining similar sensitivity. This indicates a clinically significant improvement in diagnostic performance, which supports the use of dCAD in clinical practice.
Several studies have investigated US CAD systems to diagnose thyroid malignancy 14, 16, 17, 19, 22 . SVM-based methods with textural features have been commonly used to classify thyroid nodules in these systems 14 www.nature.com/scientificreports www.nature.com/scientificreports/ have shown lower diagnostic performance than radiologists or have been based on studies retrospectively performed with a small number of thyroid nodules. Our study results were consistent with a prior prospective study evaluating the performance of sCAD, in which the CAD system showed similar sensitivity (90.7%) but lower specificity (74.6%) than an experienced radiologist 19 . Recently, Gao et al. assessed the diagnostic performance of an US CAD system based on a CNN framework, and reported similar sensitivity (96.7%) but lower specificity (48.5%) than an experienced radiologist 17 . Our method uses not only an input image, but also US feature information defined in TI-RADS, which radiologists have used to diagnose thyroid lesions in general. This approach may have contributed to the higher specificity in our study. Although the US features calculated by dCAD were not adjusted or used by the radiologist in this study, this approach may also potentially improve diagnostic performance in real clinical practice through interaction with users by providing TI-RADS US features as well as benign and malignant results. Nonetheless, in our study, dCAD still demonstrated higher specificity (80.0%) than the CAD system developed by Gao et al. 17 , while showing similar sensitivity, PPV, NPV, and accuracy. Our study is the first to report an US CAD system which shows comparable diagnostic performance with radiologists for diagnosing thyroid malignancy, and thus, has high potential for improving the diagnosis of thyroid nodules in actual clinical practice.
In this study, we further analyzed the diagnostic performances of radiologists and CAD systems according to experience level. Despite none of the patient and nodule characteristics differing according to the experience level of the radiologists, we found that only experienced radiologists exhibited higher specificity, PPV and accuracy than sCAD. In small thyroid nodules, experienced radiologists tended to show higher specificity and accuracy than dCAD, although without statistical significance. As the specificity range appeared to be lower in the inexperienced radiologist group in all nodules (56.8%) and the small thyroid nodule subgroup (53.3%), such differences may be attributed to the higher performance of experienced radiologists. Previous studies have shown that the accuracy of thyroid US depends on the experience of the interpreting physician 8 . In addition, whereas the CAD systems used two representative images of each thyroid nodule for assessment, the radiologists assessed thyroid nodules based on real-time US. Therefore, radiologists were able to make assessments based on more thorough imaging of each thyroid nodule, which may explain the higher performance seen in experienced radiologists. As the selection of representative images and semiautomatic segmentation would theoretically be influenced by the experience of the operator, this may also partially explain why there were no statistically significant differences between the performance measures of dCAD and sCAD in the inexperienced radiologist group. Another possible reason is the smaller sample size, as the number of included nodules in the inexperienced group was almost half the number included in the experienced group. Nevertheless, there was no significant difference in overall diagnostic performance between all radiologists and dCAD.
Interestingly, the specificity range of dCAD also appeared to be low in the inexperienced radiologist group in all nodules (70.5%) and the small thyroid nodule subgroup (46.7%). A possible reason for this is that the malignancy rate varies depending on the size of the lesion, and dCAD seems to automatically incorporate nodule size information from the input image itself to maximize overall performance, whereas sCAD is less affected by nodule size because the same feature values are extracted regardless of the size of the lesion. Therefore, the performance of dCAD may be more influenced by nodule size. On the other hand, experienced radiologists may select more representative images and achieve better lesion segmentation, which may lead to final assessments being less affected by size information.
Although most management guidelines recommend FNA for large thyroid nodules, controversy exists regarding the management of small thyroid nodules that are 1-2 cm in diameter 1, 6, [23] [24] [25] , which is why we chose to perform subgroup analysis for this size group. Yoon et al. reported that the criteria from Kim et al. 26 showed the highest specificity (83.1%), PPV (59.6%), and accuracy (84.0%) among six previously published guidelines for thyroid nodules in this subgroup 27 , which was the same criterion used in our study. As the experienced radiologist group tended to show higher specificity and accuracy than dCAD in this subgroup, our results may suggest that the performance of the CAD system using CNN may be slightly lower in this size group -however, the number of small thyroid nodules 1-2 cm in diameter included in this study was small. Considering the ability of deep learning to discover intricate structure in large data sets 28 , future additional training with an even larger data set would likely further improve performance.
When reviewing the cases that were incorrectly classified by the radiologists or the CAD systems, we found that radiologists showed excellent performance in diagnosing conventional papillary thyroid carcinoma. This would be expected, as established suspicious US features are suggestive of this cancer type 2 . All of the misclassified cancers by radiologists were either FVPTC or minimally invasive follicular thyroid carcinoma, which tend to show more benign US features 29, 30 . Although sCAD and dCAD showed a similar number of misclassified cancers, they differed in characteristics -conventional papillary thyroid carcinoma accounted for 72.7% (8 of 11) of the misclassified cancers by sCAD, whereas it accounted for only 33.3% (4 of 12) of the misclassified cancers by dCAD. Therefore, dCAD showed more similar classification results with radiologists, with 50% of its misclassified cancers overlapping with those of radiologists. Our results imply that deep learning-based methods not only improves diagnostic performance compared to SVM-based methods, but also in a direction similar to assessments made by radiologists.
Our study had several limitations. First, this study was conducted at a single academic center. As our institution is a referral center and we included thyroid nodules that underwent surgical excision or FNA, the overall malignancy rate was high (54.5%). In addition, a selection bias was inevitable since we excluded thyroid nodules with nondiagnostic or indeterminate cytology or histology. Further multi-center validation studies would be required to confirm our results. Second, the inexperienced radiologist group was composed of trainee fellows, who had varying experience with thyroid imaging during their residencies. Different results may be obtained in physicians with lower experience levels -however, our results still demonstrated differences in performances according to the experience level of the radiologists. Third, the experienced and inexperienced radiologist group assessed different thyroid nodules. Although characteristics of the validation data set did not differ between the two groups, this could have affected performance measures. Finally, a majority of the included malignancies were papillary thyroid carcinoma (95.5%), and thus, the diagnostic performance of the CAD systems may differ in populations with higher prevalence of other types of thyroid cancer.
In conclusion, the thyroid US CAD system using deep learning showed comparable performance with radiologists in diagnosing thyroid malignancy, regardless of the experience level of the radiologists. The newly developed CAD system is a promising tool for the assessment of thyroid nodules on US, by showing improved specificity, PPV and accuracy without loss of sensitivity.
Methods
This prospective study was supported by a grant from Samsung Medison Co. in Seoul, South Korea, which also provided the equipment for this study. The study protocol was reviewed and approved by the Institutional Review Board of Severance hospital. Written informed consent was obtained from all patients before each US examination. All methods were performed in accordance with the relevant guidelines and regulations. patients. Patients were prospectively recruited at our hospital, a tertiary referral center, between June 2016 and February 2017. Potentially eligible patients were those requiring US for preoperative evaluation or those who underwent US-guided FNA for the diagnosis of thyroid nodules ≥ 5 mm. Patients with typical benign purely cystic nodules were also eligible. Only patients who received a malignant or benign diagnosis were included in the final study population. A malignant diagnosis was confirmed by surgical pathology or by CNB histology or FNA cytology. A benign diagnosis was confirmed by surgical pathology or CNB histology, FNA cytology, or US findings of benign purely cystic nodules 1 . In total, 1501 nodules in 1326 patients (mean age, 46.4 years ± 12.9; range, 19 to 85 years) with a definitive diagnosis were included (Fig. 1) . All of the US images were acquired with a RS80A US system (Samsung Medison Co., Seoul, South Korea).
In this study, 1215 thyroid nodules diagnosed at our institution were used to develop a thyroid US CAD system using deep learning (S-Detect for thyroid, now loaded on RS85, Samsung Medison Co., Seoul, South Korea; referred to as dCAD), in addition to 3704 other thyroid nodules obtained from two other institutions using three US systems (iU22, Philips Healthcare, Bothell, WA, USA; EUB-7500, Hitachi Medical Systems, Tokyo, Japan; and RS80A, Samsung Medison Co., Seoul, South Korea). Therefore, US images of 4919 thyroid nodules from three institutions were used as a development data set for dCAD, which applied CNNs to classify thyroid nodules. An additional 286 thyroid nodules in 265 patients (213 women and 52 men; mean age, 47.2 years ± 13.2 [standard deviation]; mean nodule size, 16. 3 mm ± 10.9) diagnosed at our institution were used as an independent validation data set for which the performance of dCAD was prospectively evaluated.
US examination and assessment by radiologists. Ten radiologists including four faculty members,
with 5-20 years of experience in thyroid imaging, and six fellows training in thyroid radiology were involved in image acquisition. US examinations were performed with a 3-12-MHz linear high-frequency probe using a RS80A US system (Samsung Medison Co., Seoul, South Korea). US features of each thyroid nodule were prospectively recorded by the radiologist who performed the US or US-guided FNA, according to composition, echogenicity, margin, shape and calcifications 26 . Marked hypoechogenicity, microlobulated or irregular margins, microcalcifications, and nonparallel shape were considered as US features suspicious for malignancy 26 . When thyroid nodules exhibited at least one of the suspicious US features, they were assessed as "suspicious". When thyroid nodules had no suspicious US features, there were assessed as "probably benign". US-guided FNA was performed on nodules assessed as suspicious or on the largest nodule when there were only probably benign nodules. www.nature.com/scientificreports www.nature.com/scientificreports/ Data acquisition for the cAD system. The first version of the commercial thyroid US CAD software (S-Detect for Thyroid loaded on RS80A, Samsung Medison Co., Seoul, South Korea; referred to as sCAD) was integrated into the US system when US examinations were performed for this study. This CAD software let the user select two points indicating the top-left and bottom-right of a region of interest (ROI) box that included the thyroid nodule of interest in the US system 19 . Based on the ROI box, the CAD software calculated the nodule contour for segmentation. The software also provided a series of other candidates for nodule segmentation, from which the user was allowed to select if considered more accurate. When the semiautomatic segmentation included the adjacent normal thyroid tissue or neck structures, the user was allowed to manually select a point along the nodule margin, and the software would recalculate the nodule contour (Fig. 2) . US features of the segmented nodule, including shape (ovoid-to-round or irregular), orientation (parallel or non-parallel), margin (ill-defined or microlobulated/spiculated or well-defined), echogenicity (hyper/isoechogenicity or hypoechogenicity), composition (cystic or partially cystic or solid) and spongiform appearance were quantified by the software. Consequently, the software automatically displayed the features of the nodule in real time, and presented a diagnosis as to whether the nodule was possibly benign or malignant. This process was performed twice for each nodule, on one representative image each for the transverse and longitudinal view, respectively. The US features and diagnosis provided by sCAD were later recorded for data analysis, but were not used by the radiologist for final clinical assessment.
Development of thyroid US cAD system using deep learning (dcAD). The development of dCAD
consists of three steps. The first is the segmentation step to extract the boundaries of a lesion and the second is the classification step to extract the US features of the lesion. The last is the classification step to determine whether the lesion is benign or malignant (Fig. 3) . The segmentation algorithm for extracting the boundaries of the lesion uses a modified algorithm based on a Fully Convolutional Network (FCN) 31 . The FCN is an algorithm for fully automated segmentation. However, lesions, especially thyroid lesions, are often not clear on US images, so a semi-automated segmentation method is used to reduce errors by specifying the location of the lesion with a bounding box. In the preprocessing module, the input image is transformed using the bounding box input selected by the user. That is, segmentation is performed on the area with some margins added to the bounding box. Because the lesion is located at the center of the modified image, the central region is enhanced in feature layers to improve segmentation performance.
In the second step, a new rectangular region is generated using the lesion boundary extracted in the first step, and this region is classified as an input image. In the pre-processing module, three images with different margins are generated for the input image. This is to analyze not only the lesion area but also the farther peripheral area together. We used AlexNet 32 , a type of CNN to output classification results for seven US features including composition (cystic or partially cystic or solid), echogenicity (hyper/isoechogenicity or hypoechogenicity) orientation (parallel or non-parallel), margin (ill-defined or microlobulated/spiculated or well-defined,), spongiform (appearance, non-appearance), shape (ovoid-to-round or irregular), and calcification (macrocalcifications, microcalcifications, no calcifications) for one image input.
In the third and last classification step, the lesion area which was obtained in the first step is used as an input image, and the US features which were obtained in the second step are integrated in the feature layer of the image to the lesion as benign or malignant. We modified GoogLeNet to take grayscale images as input and to have 2-class output of benign/malignant and removed two auxiliary classifiers 33 . We trained our network with ImageNet dataset which was converted into grayscale images and then used as a pre-trained model 34 . CNN training was implemented with the Caffe deep learning framework, using a NVidia K40 GPU on Ubuntu 12.04. A model snapshot with the lowest validation loss was taken for the final model. The learning hyperparameters were 
